These findings suggest that mutant, activated SHP2 triggers proinflammatory gene expression in HSPCs both in sporadic JMML patients and in our zebrafish model of syndromic JMML-like MPN in a similar manner, suggesting a common underlying, endogenously driven process. The gene discussed is PTPN11; the disease is myeloproliferative disorder.